EDUCATION

Undergraduate Degree

  • University of Michigan , 1991 , Ann Arbor , MI

Medical School

  • University of California, David Geffen School of Medicine , 1995 , Los Angeles , CA

Residency

  • Cedars Sinai Medical Center , 1999 , Los Angeles , CA

Fellowship

  • Mattel Children’s Hospital at UCLA , 2003 , Los Angeles , CA

Graduate Degree

  • University of California Los Angeles School of Public Health , 2005 , Los Angeles , CA

Philosophy of Care

With experience as both a pediatric and adult congenital cardiologist, I have had the privilege of caring for patients with congenital heart disease across the age spectrum. From neonates to those in their 70s and still going strong, I learn from my patients and their families every day. They constantly reinforce that care is not only about the heart condition, but about the person with the heart condition. Working with our BACH adult congenital team and other Heart Center teams, I strive to give my patients the best care available and to keep them as healthy as possible now and for the decades to come.

PROFESSIONAL HISTORY

Dr. Gurvitz is an assistant professor of pediatrics at Harvard Medical School and a staff cardiologist with the Boston Adult Congenital Heart program at Boston Children’s Hospital and Brigham and Women’s Hospital. Dr. Gurvitz is board certified in pediatrics, internal medicine and pediatric cardiology and has a Master’s degree in Health Services Research. Currently, Dr. Gurvitz divides her time between research, clinical care, and administrative activities. Dr. Gurvitz also sits on a number of committees and advisory boards regarding care of adults with CHD. These include the Medical Advisory Board of the Adult Congenital Heart Association, steering committee of the Congenital Heart Public Health Consortium, founding member of the Alliance for Adult Research in Congenital Cardiology, member of the adult congenital committees of the American Heart Association and the American College of Cardiology. Dr. Gurvitz also maintains an active clinical practice seeing adolescents and adults with congenital heart disease

CERTIFICATIONS

  • American Board of Internal Medicine
  • American Board of Internal Medicine, Adult Congenital Heart Disease
  • American Board of Pediatrics, Pediatric Cardiology

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Atrial pacing in Fontan patients: The effect of transvenous lead on clot burden. Heart Rhythm. 2021 Jun 25. View abstract
  2. Association of Damaging Variants in Genes With Increased Cancer Risk Among Patients With Congenital Heart Disease. JAMA Cardiol. 2021 Apr 01; 6(4):457-462. View abstract
  3. Differences in perceptions of transition readiness between parents and teens with congenital heart disease: do parents and teens agree? Cardiol Young. 2021 Jan 11; 1-8. View abstract
  4. Difference in the prevalence of intracardiac thrombus on the first presentation of atrial fibrillation versus flutter in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2020 12; 31(12):3243-3250. View abstract
  5. Resynchronizing Right and Left Ventricles With Right Bundle Branch Block in the Congenital Heart Disease Population. JACC Clin Electrophysiol. 2020 12; 6(14):1762-1772. View abstract
  6. Patient Sharing and Health Care Utilization Among Young Adults With Congenital Heart Disease. Med Care Res Rev. 2020 Jul 29; 1077558720945925. View abstract
  7. Interobserver agreement of the anatomic and physiological classification system for adult congenital heart disease. Am Heart J. 2020 11; 229:92-99. View abstract
  8. Characteristics of Adults With Congenital Heart Defects in the United States. J Am Coll Cardiol. 2020 07 14; 76(2):175-182. View abstract
  9. Adult Congenital Heart Disease-Preparing for the Changing Work Force Demand. Cardiol Clin. 2020 Aug; 38(3):283-294. View abstract
  10. Adverse Pregnancy Conditions Among Privately Insured Women With and Without Congenital Heart Defects. Circ Cardiovasc Qual Outcomes. 2020 06; 13(6):e006311. View abstract
  11. Transition Readiness in Teens and Young Adults with Congenital Heart Disease: Can We Make a Difference? J Pediatr. 2020 06; 221:201-206.e1. View abstract
  12. Coronavirus Disease 2019 (COVID-19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease. J Am Heart Assoc. 2020 06 16; 9(12):e017224. View abstract
  13. Echocardiography-guided determination of reliable atrial pacing in a patient with congenital heart disease. HeartRhythm Case Rep. 2020 Jul; 6(7):445-447. View abstract
  14. Assessing Pregnancy, Gestational Complications, and Co-morbidities in Women With Congenital Heart Defects (Data from ICD-9-CM Codes in 3 US Surveillance Sites). Am J Cardiol. 2020 03 01; 125(5):812-819. View abstract
  15. Cancer Risk in Congenital Heart Disease-What Is the Evidence? Can J Cardiol. 2019 Dec; 35(12):1750-1761. View abstract
  16. Receipt of American Heart Association-Recommended Preconception Health Care Among Privately Insured Women With Congenital Heart Defects, 2007-2013. J Am Heart Assoc. 2019 09 17; 8(18):e013608. View abstract
  17. Increasing Evidence for and a Word of Caution About an Association Between Cancer and Congenital Heart Disease. JAMA Netw Open. 2019 07 03; 2(7):e196756. View abstract
  18. Surveillance of Congenital Heart Defects among Adolescents at Three U.S. Sites. Am J Cardiol. 2019 07 01; 124(1):137-143. View abstract
  19. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 04 02; 139(14):e637-e697. View abstract
  20. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 04 02; 139(14):e698-e800. View abstract
  21. Population-based surveillance of congenital heart defects among adolescents and adults: surveillance methodology. Birth Defects Res. 2018 11 15; 110(19):1395-1403. View abstract
  22. Frontiers in Fontan failure: Innovation and improving outcomes: A conference summary. Congenit Heart Dis. 2019 Mar; 14(2):128-137. View abstract
  23. A National Population-based Study of Adults With Coronary Artery Disease and Coarctation of the Aorta. Am J Cardiol. 2018 12 15; 122(12):2120-2124. View abstract
  24. Epidemiology of ACHD: What Has Changed and What is Changing? Prog Cardiovasc Dis. 2018 Sep - Oct; 61(3-4):275-281. View abstract
  25. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 04 02; 73(12):1494-1563. View abstract
  26. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 04 02; 73(12):e81-e192. View abstract
  27. A Pilot Study of Inspiratory Muscle Training to Improve Exercise Capacity in Patients with Fontan Physiology. Semin Thorac Cardiovasc Surg. 2018 Winter; 30(4):462-469. View abstract
  28. Stroke in Adults With Coarctation of the Aorta: A National Population-Based Study. J Am Heart Assoc. 2018 06 01; 7(11). View abstract
  29. Transition Education: Formative Steps, in Need of Direction. J Am Coll Cardiol. 2018 04 24; 71(16):1778-1780. View abstract
  30. College students with congenital heart disease: A critical time for transition. J Am Coll Health. 2018 May-Jun; 66(4):324-328. View abstract
  31. Association of Albuminuria With Major Adverse Outcomes in Adults With Congenital Heart Disease: Results From the Boston Adult Congenital Heart Biobank. JAMA Cardiol. 2018 04 01; 3(4):308-316. View abstract
  32. Outcomes of Patients With Hypoplastic Left Heart Syndrome Reaching Adulthood After Fontan Palliation: Multicenter Study. Circulation. 2018 02 27; 137(9):978-981. View abstract
  33. Fontan-Associated Liver Disease: Proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC. J Am Coll Cardiol. 2017 12 26; 70(25):3173-3194. View abstract
  34. Exposure to Low-Dose Ionizing Radiation From Cardiac Procedures and Malignancy Risk in Adults With Congenital Heart Disease. Circulation. 2018 03 27; 137(13):1334-1345. View abstract
  35. Development of Quality Metrics in Ambulatory Pediatric Cardiology. J Am Coll Cardiol. 2017 Feb 07; 69(5):541-555. View abstract
  36. Advancing the Measurement of Care Coordination in Pediatric Behavioral Health. J Dev Behav Pediatr. 2016 10; 37(8):674-84. View abstract
  37. Prevalence of Cancer in Adults With Congenital Heart Disease Compared With the General Population. Am J Cardiol. 2016 Dec 01; 118(11):1742-1750. View abstract
  38. Emerging Research Directions in Adult Congenital Heart Disease: A Report From an NHLBI/ACHA Working Group. J Am Coll Cardiol. 2016 Apr 26; 67(16):1956-64. View abstract
  39. Exposure to Low-Dose Ionizing Radiation From Cardiac Procedures in Patients With Congenital Heart Disease: 15-Year Data From a Population-Based Longitudinal Cohort. Circulation. 2016 Jan 05; 133(1):12-20. View abstract
  40. Hybrid Approach for Off-Pump Pulmonary Valve Replacement in Patients With a Dilated Right Ventricular Outflow Tract. Ann Thorac Surg. 2015 Nov; 100(5):e99-101. View abstract
  41. Evaluation of Health Care Quality in Adults with Congenital Heart Disease. Cardiol Clin. 2015 Nov; 33(4):635-41, ix-x. View abstract
  42. Feasibility of Using Electronic Medical Record Data for Tracking Quality Indicators in Adults with Congenital Heart Disease. Congenit Heart Dis. 2015 Nov-Dec; 10(6):E268-77. View abstract
  43. Survival of adults with ASD2: a call for a longitudinal clinical registry. Eur Heart J. 2015 Aug 14; 36(31):2036-2038. View abstract
  44. Electronic medical record integration with a database for adult congenital heart disease: Early experience and progress in automating multicenter data collection. Int J Cardiol. 2015 Oct 01; 196:178-82. View abstract
  45. Task Force 6: Pediatric Cardiology Fellowship Training in Adult Congenital Heart Disease. J Am Coll Cardiol. 2015 Aug 11; 66(6):723-31. View abstract
  46. Task Force 6: Pediatric Cardiology Fellowship Training in Adult Congenital Heart Disease. SPCTPD/ACC/AAP/AHA. Circulation. 2015 Aug 11; 132(6):e91-8. View abstract
  47. 2015 SPCTPD/ACC/AAP/AHA Training Guidelines for Pediatric Cardiology Fellowship Programs (Revision of the 2005 Training Guidelines for Pediatric Cardiology Fellowship Programs). J Am Coll Cardiol. 2015 Mar 13. View abstract
  48. Current and future status of adult congenital training in North America. Am J Cardiol. 2015 Apr 15; 115(8):1151-3. View abstract
  49. Clinicians' perspectives on patient satisfaction in adult congenital heart disease clinics--a dimension of health care quality whose time has come. Congenit Heart Dis. 2015 Mar-Apr; 10(2):128-36. View abstract
  50. Transition in congenital heart disease: it takes a village. Heart. 2014 Jul; 100(14):1075-6. View abstract
  51. Clinical research priorities in adult congenital heart disease. Int J Cardiol. 2014 Feb 15; 171(3):351-60. View abstract
  52. Heart failure in pregnant women with cardiac disease: data from the ROPAC. Heart. 2014 Feb; 100(3):231-8. View abstract
  53. Building quality indicators to improve care for adults with congenital heart disease. J Am Coll Cardiol. 2013 Dec 10; 62(23):2244-53. View abstract
  54. Public health science agenda for congenital heart defects: report from a Centers for Disease Control and Prevention experts meeting. J Am Heart Assoc. 2013 Aug 28; 2(5):e000256. View abstract
  55. Improving heart disease knowledge and research participation in adults with congenital heart disease (the Health, Education and Access Research Trial: HEART-ACHD). Int J Cardiol. 2013 Oct 09; 168(4):3236-40. View abstract
  56. Prevalence and predictors of gaps in care among adult congenital heart disease patients: HEART-ACHD (The Health, Education, and Access Research Trial). J Am Coll Cardiol. 2013 May 28; 61(21):2180-4. View abstract
  57. Left and right ventricular diastolic function in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Can J Cardiol. 2013 Jul; 29(7):866-72. View abstract
  58. Hospitalizations and mortality in the United States for adults with Down syndrome and congenital heart disease. Am J Cardiol. 2013 Apr 01; 111(7):1046-51. View abstract
  59. Aortic root dilatation in adults with surgically repaired tetralogy of fallot: a multicenter cross-sectional study. Circulation. 2013 Jan 15; 127(2):172-9. View abstract
  60. Best practices in managing transition to adulthood for adolescents with congenital heart disease: the transition process and medical and psychosocial issues: a scientific statement from the American Heart Association. Circulation. 2011 Apr 05; 123(13):1454-85. View abstract
  61. Prevalence of left ventricular systolic dysfunction in adults with repaired tetralogy of fallot. Am J Cardiol. 2011 Apr 15; 107(8):1215-20. View abstract
  62. From numbers to guidelines. Prog Cardiovasc Dis. 2011 Jan-Feb; 53(4):239-46. View abstract
  63. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation. 2010 Aug 31; 122(9):868-75. View abstract
  64. The CALF (Congenital Heart Disease in Adults Lower Extremity Systemic Venous Health in Fontan Patients) study. J Am Coll Cardiol. 2010 Jul 06; 56(2):144-50. View abstract
  65. Echo rounds: intramural left coronary artery. Anesth Analg. 2010 Aug; 111(2):354-7. View abstract
  66. Electrocardiogram screening of infants for long QT syndrome: survey of pediatric cardiologists in North America. J Electrocardiol. 2010 Jan-Feb; 43(1):4-7. View abstract
  67. State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association. Circulation. 2009 Sep 22; 120(12):1141-63. View abstract
  68. Distorted cardiac anatomy: the congenital (R)evolution. J Am Soc Echocardiogr. 2009 Feb; 22(2):141-4. View abstract
  69. An unusual presentation in a patient with Shone's anomaly. Anesth Analg. 2008 Dec; 107(6):1825-7. View abstract
  70. Repaired tetralogy of Fallot in the adult: monitoring and management. Heart. 2008 Dec; 94(12):1663-9. View abstract
  71. Missed diagnosis of critical congenital heart disease. Arch Pediatr Adolesc Med. 2008 Oct; 162(10):969-74. View abstract
  72. Multicenter research in adult congenital heart disease. Int J Cardiol. 2008 Sep 26; 129(2):155-9. View abstract
  73. Considerations of a one-and-one-half ventricle repair in a 47-year-old patient. Congenit Heart Dis. 2008 Jan-Feb; 3(1):69-72. View abstract
  74. Intraoperative pulmonary artery stenting: an alternative technique for the management of pulmonary artery stenosis. Ann Thorac Surg. 2007 Oct; 84(4):1338-41; discussion 1342. View abstract
  75. Ebstein's anomaly of the tricuspid valve. Curr Cardiol Rep. 2007 Jul; 9(4):336-42. View abstract
  76. Changes in hospitalization patterns among patients with congenital heart disease during the transition from adolescence to adulthood. J Am Coll Cardiol. 2007 Feb 27; 49(8):875-82. View abstract
  77. Current practice of exercise stress testing among pediatric cardiology and pulmonology centers in the United States. Pediatr Cardiol. 2006 Jan-Feb; 27(1):110-116. View abstract
  78. Variations in adult congenital heart disease training in adult and pediatric cardiology fellowship programs. J Am Coll Cardiol. 2005 Sep 06; 46(5):893-8. View abstract
  79. Frequency of aortic root dilation in children with a bicuspid aortic valve. Am J Cardiol. 2004 Nov 15; 94(10):1337-40. View abstract
  80. Altered cerebral dominance in atopy and in children of asthmatic mothers. Ann N Y Acad Sci. 1992 Apr 15; 650:25-9. View abstract